Multimedia
View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Listen to expert insights from Joseph J. Eron, Jr., MD, on exciting data about investigational agents (dapivirine ring, islatravir, lenacapavir, broadly neutralizing antibodies) for next-generation HIV prevention.
Joseph J. Eron, Jr., MD
Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Breve vlog de la Dra. Alicia Piñeirúa Menéndez sobre la optimización del TAR en un paciente con VIH y tuberculosis activa en México de Clinical Care Options (CCO)
Alicia Piñeirúa Menéndez, MD, MPH
Released: May 20, 2022
Expert HIV faculty analyze new data from CROI 2022, from Clinical Care Options (CCO)
Joseph J. Eron, Jr., MD
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN
Jasjit Gill, BSPharm, PharmD
Registered Nurses:
1.0 Nursing contact hour
Pharmacists:
1.0 contact hour (0.1 CEUs)
Released: May 10, 2022
Expired:
May 9, 2023
Expert analysis of barriers and solutions to PrEP uptake in key populations.
Joseph J. Eron, Jr., MD
Gregory Huhn, MD, MPHTM
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Released: May 4, 2022
Expert selections of important HIV data from CROI 2022, including current and investigational strategies for prevention, ART, comorbidities, and cure
Joseph J. Eron, Jr., MD
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Daniel R. Kuritzkes, MD
Released: May 2, 2022
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.